The Framingham risk function underestimated absolute coronary heart disease risk in Czech men

Methods of Information in Medicine

Volumn 46, Issue 1, 2007, Pages 43-49

  Reissigova J ^a   Zvarova J ^a  

^a INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

Coronary heart disease; External validation; Framingham risk function

Indexed keywords

CHOLESTEROL;

ADULT; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

EID: 33847014777     PISSN: 00261270     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1627830     Document Type: Article

References (25)

1. European cardiovascular disease statistics. British heart foundation, London 2000.
2. Deaths 2003. Institute of health information and statistics of the Czech Republic, Prague 2004.
3. Anderson KM, Odell PM, Wilson PWF, et al. Cardiovascular disease risk profile. Am Heart J 1991; 121: 293-8.
4. Anderson KM, Wilson PWF, Odell PM, et al. An updated coronary risk profile, a statement for health professionals. Circulation 1991; 83: 356-62.
5. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factors categories. Circulation 1998; 97: 1837-47.
6. D'Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: New results from the Framingham Study. Am Heart J 2000; 139: 272-81.
7. D'Agostino RB Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease scores: results of a multiply ethnic groups investigation. JAMA 2001; 286: 180-7.
8. Thomsen TF, Davidsen M, Ibsen H. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk 2001; 8: 291-7.
9. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002; 105: 310-5.
10. Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
11. Boudík F, Reissigová J, Hrach K, TomeṠková M, Bultas J, Anger Z, Aschermann M, Zvárová J. Primary Prevention of Coronary Artery Disease Among Middle Aged Men in Prague: Twenty-Year Follow-up Results. Atherosclerosis 2006; 184: 86-93.
12. D'Agostino RB, Nam B-H. Evaluation of the Performance of Survival Analysis Models: Discrimination and Calibration Measures. In: Balakrishnan N, Rao CR, editors. Handbook of Statistics Volume 23: Advances in Survival Analysis. Amsterdam: Elsevier; 2004.
13. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004; 23: 2109-23.
14. Eng J. ROC analysis: web-based calculator for ROC curves. Version 1.0.2, March 2004. Web: http://www.rad.jhmi.edu/roc.
15. Coronary heart disease statistics. British Heart Foundation. London 2003.
16. Czech Health Statistics Yearbook 2002. Institute of health information and statistics of the Czech Republic, Prague 2003.
17. Empana JP, Ducimetiere P, Arveiler D, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003; 24: 1903-11.
18. Orford JL, Sesso HD, Stedman M, et al. A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J 2002; 144: 95-100.
19. Suka M, Sugimori H, Yoshida K. Validity of the Framingham risk model applied to Japanese men. Methods Inf Med 2002; 41: 213-5.
20. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21:348-50.
21. Bastuji-Garin S, Deverly A, Moyse D, et al. Intervention as a goal in hypertension treatment study group. J Hypertens 2002; 20: 1973-80.
22. Hense HW, Schulte H, Lowel H, et al. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany - results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003; 24: 937-45.
23. Brindle P, Emberson J, Lampe F, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 29: 327: 1267.
24. Marrugat J, D'Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health 2003; 57: 634-8.
25. Liu J, Hong Y, D'Agostino RB Sr, Wu Z, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 2004; 291: 2591-9.